Munich, Germany

Friedhelm Wallenhorst

This inventor holds 1 USPTO granted patent. Top assignee: Siemens Aktiengesellschaft. Active years: 1984.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Friedhelm Wallenhorst: Innovator in Chemical Gilding

Introduction

Friedhelm Wallenhorst is a notable inventor based in Munich, Germany. He has made significant contributions to the field of chemical engineering, particularly in the area of gilding processes. His innovative approach has led to the development of a unique chemical gilding bath.

Latest Patents

Wallenhorst holds a patent for a chemical gilding bath, which is formulated using an alkaline, aqueous solution of an alkali gold cyanide complex. This bath includes a reducing agent and a stabilizing agent. The reducing agent is an organic compound that contains at least one enol group within its molecular structure, such as ascorbic acid or its salts. The pH value of the bath is carefully adjusted by a buffer solution to range between approximately 7.5 to 12, with a preferred pH of about 8. This innovation enhances the efficiency and effectiveness of the gilding process.

Career Highlights

Friedhelm Wallenhorst is associated with Siemens Aktiengesellschaft, a leading global technology company. His work at Siemens has allowed him to apply his inventive skills in a practical setting, contributing to advancements in chemical processes.

Collaborations

Wallenhorst has collaborated with esteemed colleagues such as Ernst Andrascek and Hans Hadersbeck. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Friedhelm Wallenhorst's contributions to the field of chemical engineering, particularly through his patented chemical gilding bath, demonstrate his commitment to innovation. His work continues to influence the industry and inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…